GS
Therapeutic Areas
Ono Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Opdivo (nivolumab) | Various Cancers | Approved |
| Opdualag (nivo + relatlimab) | Metastatic Melanoma | Approved |
| Tebentafusp (Kimmtrak) | Uveal Melanoma | Approved |
| ONO-4578 (PT199) | Solid Tumors | Phase 1/2 |
| ONO-4685 | B-cell Malignancies / Autoimmune Diseases | Phase 1/2 |
| ONO-7701 | Cancer | Phase 1 |
| Etrasimod | Ulcerative Colitis, Atopic Dermatitis, Crohn's | Approved / Phase 3 |
| ONO-2808 | Parkinson's Disease Dementia | Phase 2 |